---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031918"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2026-07-02T20:30:31+00:00"
generated_at: "2026-07-02T20:32:27.863950+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharmaceuticals appoints Danina Fisher and Gary S. Stetz, II to board

## Summary
- Danina Fisher and Gary S. Stetz, II appointed as directors effective July 1, 2026.
- Gary S. Stetz, II is the son of Gary Stetz, the Interim CEO.
- No arrangements or understandings with any other person regarding their selection as directors.
- No family relationships exist between the new directors except the father-son relationship noted.

## SEC filing metadata
- accession: 0001493152-26-031918
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2026-07-02T20:30:31+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/0001493152-26-031918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031918
- JSON: https://secwatch.observer/filing/0001493152-26-031918.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.